Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

ClinicalTrials.gov ID: NCT01488929

Public ClinicalTrials.gov record NCT01488929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 10:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Assess Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Study identification

NCT ID
NCT01488929
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Targacept Inc.
Industry
Enrollment
603 participants

Conditions and interventions

Interventions

  • TC-5619 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Oct 31, 2013
Completion
Oct 31, 2013
Last update posted
Jun 2, 2015

2011 – 2013

United States locations

U.S. sites
22
U.S. states
10
U.S. cities
22
Facility City State ZIP Site status
Collaborative Neuroscience Network, Inc Garden Grove California 92845
Behavorial Research Specialists Glendale California 91206
Apostle Clinical Trials, Inc Long Beach California 90813
Synergy Clinical Research Center National City California 91950
Excell Research, Inc. Oceanside California 92056
Neuropsychiatric Research Center of Orange County Orange California 92868
CNRI San Diego California 92102
Segal Institute for Clinical Research Lauderhill Florida 33319
Compass Research, LLC Leesburg Florida 34749
Atlanta Center for Medical Research Atlanta Georgia 30308
Alexian Brothers Behavioral Health Hospital Hoffman Estates Illinois 60169
Precise Research Group Flowood Mississippi 39232
St. Charles Psychiatric Associates - Midwest Reserch Group Saint Charles Missouri 63304
PsychCare Consultants Research St Louis Missouri 63128
CRI Worldwide, LLC Marlton New Jersey 08053
Behavioral Medical Research Brooklyn New York 11241
Finger Lakes Clinical Research Rochester New York 14618
Neuro-Behavorial Clinic Research, Inc. Canton Ohio 44718
Midwest Clinical Research Center Dayton Ohio 45417
FutureSearch Trials of Dallas, L.P. Dallas Texas 75231
InSite Clinical Research DeSoto Texas 75115
Houston Clinical Trials, LLC Houston Texas 77098

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01488929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2015 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01488929 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →